Natco Pharma Ltd share price logo

Natco Pharma Share Price

NSE: NATCOPHARM

BSE: 524816

Small Cap

Healthcare Sector

₹862.20

+13.95

(+1.64%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Natco Pharma Stock Performance

as on September 12, 2025 at 4:02 pm IST

  • Day's Low

    Day's High

    ₹850.25
    ₹864.8
    downward going graph

    1.39%

    Downside

    0.30%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹726.8
    ₹1,639
    downward going graph

    15.70%

    Downside

    90.10%

    Upside

    downward going graph

Natco Pharma share price movements today

Previous Close
₹848.25
Open
₹856.85
Volume
2.88L
Upper Circuit
₹1,017.90
Lower Circuit
₹678.60
Day's Low - High
₹850.25 - ₹864.8
52 Week Low - High
₹726.8 - ₹1,639

Natco Pharma Historical Returns

1 Month Return
-4.65 %
3 Month Return
-5.53 %
1 Year Return
-45.52 %
3 Year Return
+ 38.12 %
5 Year Return
+ 10.17 %

Natco Pharma Fundamentals

as on September 12, 2025 at 4:02 pm IST

Market Cap

₹15,442.85 Cr

Return on Equity (ROE)

28.63

PE Ratio (TTM)

9.1

Return on capital employed (ROCE)

32.75

Industry PE ratio

42.64

Beta (LTM)

0.94

P/B Ratio

1.95

Dividend Yield

0.75

PEG Ratio

2.66

Quarterly Earnings Growth YOY

-28.15

EPS (TTM)

105.22

Sector

Pharmaceuticals

Book Value

424.97

Technical Analysis

Bearish

View Technical Analysis

Natco Pharma Stock Valuation

as on September 12, 2025 at 4:02 pm IST

Natco Pharma in the last 5 years

  • Overview

  • Trends

Lowest (7.09x)

April 9, 2025

Today (9.10x)

September 12, 2025

Industry (42.64x)

September 12, 2025

Highest (90.32x)

April 6, 2022

LowHigh

Today’s Price to Earnings Ratio: 9.10x

Natco Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Natco Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD15,442.852.03%0.521,8834,429
Sanofi India Ltd image
Sanofi India Ltd
BUY11,669.30-8.08%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY64,125.127.49%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD1,05,126.3036.7%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY65,832.5017.51%0.001,4146,445
See all

Analyst Recommendation on Natco Pharma Stock

Based on 11 analysts

HOLD

30.00%

Buy

20.00%

Hold

50.00%

Sell

Based on 11 analysts, 50% of analysts recommend a 'HOLD' rating for Natco Pharma. Average target price of ₹982.64

Source: S&P Global Market Intelligence

Natco Pharma Share Price Target

Get share price movements and forecasts by analysts on Natco Pharma.

What analysts predicted

13.97%UPSIDE

Target Price

₹982.64

Current Price

₹862.2

Analyzed by

11 Analysts

High

₹1480

Target

₹982.64

Low

₹712

Natco Pharma target price ₹982.64, a slight upside of 13.97% compared to current price of ₹862.2. According to 11 analysts rating.

Source: S&P Global Market Intelligence

Natco Pharma Stock's Interest Amongst Investors

Investment in Natco Pharma Ltd Shares on INDmoney has grown by 20.26% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:20.26% versus previous 30 day period

Search interest for Natco Pharma Ltd Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-24% versus previous 30 day period

Natco Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
432.1
492.5
897.9
1,140.5
1,031.4
758.6
1,068.3
1,362.6
1,371.1
474.8
1,221
1,328.9
Other Income
20.5
20.8
29
19.7
29.4
37
42
48.1
63.8
176.3
66.3
61.7
Total Income
452.6
513.3
926.9
1,160.2
1,060.8
795.6
1,110.3
1,410.7
1,434.9
651.1
1,287.3
1,390.6
Expenses
336.8
386.6
558.8
612.5
573.4
490.5
571
557.8
566.8
436
672.9
757.9
Operating Profit
95.3
105.9
339.1
528
458
268.1
497.3
804.8
804.3
38.8
548.1
571
Operating Profit Margin %
22.06%
21.5%
37.77%
46.3%
44.41%
35.34%
46.55%
59.06%
58.66%
8.17%
44.89%
42.97%
Profit Before Interest, Tax and Depreciation
115.8
126.7
368.1
547.7
487.4
305.1
539.3
852.9
868.1
215.1
614.4
632.7
Interest
3.8
3.8
2.7
4.2
4.2
4.6
6.2
5.2
4.1
4.4
10.2
3.2
Depreciation
41.7
41.5
41
43.5
43.6
44.2
55.5
44.1
45.8
47
98.3
57.6
Profit Before Tax
70.3
81.4
324.4
500
439.6
256.3
477.6
803.6
818.2
163.7
505.9
571.9
Tax Paid
13.5
19.1
48.6
79.7
70.6
43.6
91.3
135.1
141.7
31.3
99.9
91.6
Profit After Tax
56.8
62.3
275.8
420.3
369
212.7
386.3
668.5
676.5
132.4
406
480.3
Total Net profit including share of profit / Loss from associate company
56.8
62.3
275.8
420.3
369
212.7
386.3
668.5
676.5
132.4
406
480.3
EPS
3.11
3.41
15.11
23.26
20.6
11.88
21.56
37.32
37.81
7.43
22.7
26.84
Actual EPS
3.11
3.41
15.11
23.26
20.6
11.88
21.56
37.32
37.81
7.43
22.7
26.84
Adjusted EPS
3.11
3.41
15.11
23.26
20.6
11.88
21.56
37.32
37.81
7.43
22.7
26.84
Diluted EPS
3.11
3.41
15.11
23.26
20.6
11.88
21.56
37.32
37.81
7.43
22.7
26.84

Natco Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
2,020.2
2,184.8
2,094.5
1,915
2,052.1
1,944.8
2,707.1
3,998.8
4,429.5
Other Income
13.9
40.4
130.2
107.4
103.6
99
104.6
128.1
354.5
Total Income
2,034.1
2,225.2
2,224.7
2,022.4
2,155.7
2,043.8
2,811.7
4,126.9
4,784
Expenses
1,336.8
1,256.4
1,299.7
1,332.4
1,445.9
1,681.3
1,771.5
2,247.4
2,233.5
Operating Profit
683.4
928.4
794.8
582.6
606.2
263.5
935.6
1,751.4
2,196
Operating Profit Margin %
33.83%
42.49%
37.95%
30.42%
29.54%
13.55%
34.56%
43.8%
49.58%
Profit Before Interest, Tax and Depreciation
697.3
968.8
925
690
709.8
362.5
1,040.2
1,879.5
2,550.5
Interest
18.5
15.4
19.3
21.5
13.3
17.7
14.5
19.2
23.9
Depreciation
54.4
66.2
81
99.8
116.9
142.6
163.8
186.8
235.2
Profit Before Tax
624.4
887.2
824.7
568.7
579.6
202.2
861.9
1,673.5
2,291.4
Tax Paid
139.5
192
182.3
110.6
137.2
32.2
146.6
285.2
408
Profit After Tax
484.9
695.2
642.4
458.1
442.4
170
715.3
1,388.3
1,883.4
Total Net profit including share of profit / Loss from associate company
484.9
695.2
642.4
458.1
442.4
170
715.3
1,388.3
1,883.4
EPS
27.78
39.26
34.98
25.33
24.2
9.32
39.18
77.34
105.26
Actual EPS
27.78
39.26
34.98
25.33
24.2
9.32
39.18
77.34
105.26
Adjusted EPS
27.78
39.26
34.98
25.33
24.2
9.32
39.18
77.34
105.26
Diluted EPS
27.75
39.13
34.87
25.26
24.16
9.32
39.18
77.34
105.26

Natco Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
92.67
112.2
345.8
463.6
668.8
417.3
298.8
46.5
849.1
1,211.6
Cash Flow from Investing Activities
-119.52
-176.3
-298.8
-1,116.3
-611.3
-175
-107.1
4
-465.3
-1,026.2
Cash Flow from Financing Activities
29.07
154
-47.7
650.9
-50.9
-250.8
-185.7
34.8
-363
-246.9
Net Cash Flow
2.23
89.9
-0.7
-1.8
6.6
-8.5
6
85.3
20.8
-61.5

Natco Pharma Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
48.8%
48.82%
48.84%
49.76%
49.71%
49.71%
49.71%
49.71%
49.62%
49.62%
49.56%
49.56%
DII
13.7%
14.93%
15.38%
15.02%
14.01%
11.23%
9.7%
7.87%
6.75%
5.57%
5.65%
5.82%
FII
0%
0%
0%
0%
0%
0%
16.14%
17.45%
17.51%
17.94%
17.49%
15.51%
Public
25.23%
24.53%
23.87%
24.07%
23.46%
25.32%
24.45%
24.97%
26.12%
26.87%
27.29%
29.11%
Total Outstanding Shares
18,25,57,165
18,25,57,165
18,24,70,115
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
Total Shareholders
1,21,336
1,35,397
1,53,663
1,55,181
1,63,753
2,07,571
2,28,467
2,51,485
3,02,944
3,45,332
4,05,222
4,29,434

Mutual Funds that own Natco Pharma Stock

Check out the Mutual Funds with significant holdings in Natco Pharma.

Natco Pharma Earnings and Dividends

View detailed summary of the earnings and dividend history of Natco Pharma.

  • Natco Pharma Ltd Earnings Results

    Natco Pharma Ltd’s net profit fell -28.09% since last year same period to ₹480.70Cr in the Q1 2025-2026. On a quarterly growth basis, Natco Pharma Ltd has generated 18.22% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Natco Pharma Ltd Dividends August,2025

    In the quarter ending June 2025, Natco Pharma Ltd has declared dividend of ₹2.00 per share on 12 Aug 2025 - translating a dividend yield of 0.93%.

    Read More about Dividends

Indices Featuring Natco Pharma Stock

Check stock indices that include Natco Pharma.

Nifty Small 100

₹17,989.90

0.64 (▲114.7%)

Nifty Smallcap 50

₹8,647.70

0.47 (▲40.6%)

NIFTY PHARMA

₹22,341.20

0.53 (▲117.2%)

BSE 500

₹36,418.62

0.36 (▲130.71%)

Nifty Smallcap 250

₹17,144.85

0.32 (▲54.35%)

S&P BSE SmallCap Select

₹8,048.65

0.59 (▲47%)

Nifty 500

₹23,190.25

0.38 (▲87.6%)

S&P BSE 250 SmallCap

₹6,862.99

0.34 (▲23.19%)

S&P BSE 400 MidSmallCap

₹12,115.23

0.2 (▲24.61%)

BSE Healthcare

₹44,922.57

0.27 (▲120.98%)

Nifty MidSmallcap 400

₹19,984.85

0.29 (▲58%)

BSE Small-Cap

₹53,548.49

0.27 (▲146.11%)

Insights on Natco Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.85% to 2.11% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 133.0 Cr → 480.7 Cr (in ₹), with an average increase of 41.4% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 27.29% to 29.11% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 651.1 Cr → 1.39K Cr (in ₹), with an average increase of 28.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 9.6% return, outperforming this stock by 55.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 49.56% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.9% return, outperforming this stock by 97.8%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 17.49% to 15.51% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, NATCOPHARM stock has moved down by -45.5%

About Natco Pharma Ltd

Natco Pharma Limited is an international, RD focused pharmaceutical company that specialises in the development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). Natco sells products in over 40 countries, and provides contract manufacturing services for other pharmaceutical companies. The company was originally founded in 1981, and has since enjoyed significant growth, launching a variety of products and earning a number of milestones such as a compulsory license from Bayer for its patent protected anticancer drug Nexavar in 2012, and various first-to-market generic drugs including HEPCINAT (generic Sofosbuvir) and Epclusa (a single tablet regimen for the treatment of genotypes 2 and 3 chronic hepatitis C virus HCV infection). In 2021, Natco had 8 launches in the domestic market and acquired Dash Pharmaceuticals LLC in the US. Natco has 8 international subsidiaries, including the Philippines, Australia, Brazil and the US, constantly achieving the first generic to market for a variety of drugs. Natco's ambition for growth looks set to continue in 2022, with a number of new launches planned.

Revenue: ₹1,328.90Cr as on June 2025 (Q1 FY26)
Net Profit: ₹480.30Cr as on June 2025 (Q1 FY26)
Listing date: 27 Dec, 1995
Chairperson Name: G S Murthy
OrganisationNatco Pharma Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOG S Murthy
E-voting on sharesClick here to vote

FAQs

What is Natco Pharma share price today?

Natco Pharma share price today stands at ₹862.2 as on at the close of the market. Natco Pharma share today touched a day high of ₹864.8 and a low of ₹850.25.

What is the 52 week high and 52 week low range for Natco Pharma share?

Natco Pharma touched a 52 week high of ₹1639 and a 52 week low of ₹726.8. Natco Pharma share price today i.e. is closed at ₹862.2, which is -47.39% down from its 52 week high and 18.63% up from its 52 week low.

What is Natco Pharma's market capitalisation today?

Natco Pharma market capitalisation is ₹15,442.85 Cr as on .

How to buy Natco Pharma shares?

To buy Natco Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NATCOPHARM or Natco Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Natco Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Natco Pharma trading volume today?

Natco Pharma trading volume is 2.88L as on . This means that 2.88L shares of Natco Pharma were bought and sold on the stock market during today's trading session.